These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7940738)

  • 21. Generation and characterization of a single-gene encoded single-chain immunoglobulin-interleukin-2 fusion protein.
    Shu L; Qi CF; Hand PH; Schlom J; Kashmiri SV
    Immunotechnology; 1995 Dec; 1(3-4):231-41. PubMed ID: 9373351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response.
    Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H
    J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
    Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
    Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells.
    Verhagen AM; Brandon MR; Nash AD
    Immunology; 1993 Jul; 79(3):471-8. PubMed ID: 8406574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of rat-mouse T cell hybridomas that express regulatable rat interleukin 2 receptor.
    Kohda H; Uede T; Yuasa H; Yamaki T; Osawa H; Diamantstein T; Yodoi J; Kikuchi K
    J Immunol; 1986 Sep; 137(5):1557-63. PubMed ID: 3091685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
    Tanaka K; Turka LA; Kupiec-Weglinski JW; Milford EL; Ueda H; Diamantstein T; Carpenter CB; Tilney NL
    Transplantation; 1990 Jul; 50(1):125-31. PubMed ID: 2142344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity.
    Kim YS; Maslinski W; Zheng XX; Stevens AC; Li XC; Tesch GH; Kelley VR; Strom TB
    J Immunol; 1998 Jun; 160(12):5742-8. PubMed ID: 9637483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.
    Kunzendorf U; Pohl T; Bulfone-Paus S; Krause H; Notter M; Onu A; Walz G; Diamantstein T
    J Clin Invest; 1996 Mar; 97(5):1204-10. PubMed ID: 8636431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens.
    Kelley VE; Naor D; Tarcic N; Gaulton GN; Strom TB
    J Immunol; 1986 Oct; 137(7):2122-4. PubMed ID: 3093566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2-dependent autocrine proliferation in T-cell development.
    Toribio ML; Gutiérrez-Ramos JC; Pezzi L; Marcos MA; Martínez C
    Nature; 1989 Nov; 342(6245):82-5. PubMed ID: 2812004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction.
    Ierino FL; Powell MS; McKenzie IF; Hogarth PM
    J Exp Med; 1993 Nov; 178(5):1617-28. PubMed ID: 8228810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
    Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
    J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
    Vie H; Bonneville M; Sondermeyer P; Moreau JF; Soulillou JP
    Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chimeric IL-2/Ig molecule possesses the functional activity of both proteins.
    Landolfi NF
    J Immunol; 1991 Feb; 146(3):915-9. PubMed ID: 1988502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
    Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR
    J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms.
    Tsudo M; Karasuyama H; Kitamura F; Tanaka T; Kubo S; Yamamura Y; Tamatani T; Hatakeyama M; Taniguchi T; Miyasaka M
    J Immunol; 1990 Jul; 145(2):599-606. PubMed ID: 2365996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2-IgG2b fusion protein suppresses murine contact hypersensitivity in vivo.
    Rückert R; Brandt K; Hofmann U; Bulfone-Paus S; Paus R
    J Invest Dermatol; 2002 Aug; 119(2):370-6. PubMed ID: 12190859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).
    Shindo T; Sugie K; Nakamura K; Tagaya Y; Maeda M; Uchiyama T; Sagawa K; Yokoyama M; Wada H; Hitomi S
    Immunology; 1990 Sep; 71(1):63-9. PubMed ID: 2170270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.